Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MOBILE: BIIB014 in Early Parkinson's Disease
NCT00442780Phase 2Completed
- Sponsor
- Biogen
- Start
- Aug 2007
- Primary completion
- Dec 2008
- Countries
- 3
01
Overview
A Phase 2 trial of vipadenant in Parkinson's disease (PD), sponsored by Biogen. Started Aug 2007; status: completed.
02
Drugs
vipadenant
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00442780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00442780.